Raiffeisen Bank International AG Purchases 4,325 Shares of Veeva Systems Inc. $VEEV

Raiffeisen Bank International AG raised its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 2,790.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,480 shares of the technology company’s stock after purchasing an additional 4,325 shares during the period. Raiffeisen Bank International AG’s holdings in Veeva Systems were worth $789,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Tudor Financial Inc. lifted its holdings in Veeva Systems by 497.7% in the second quarter. Tudor Financial Inc. now owns 3,150 shares of the technology company’s stock worth $559,000 after buying an additional 2,623 shares during the period. Concurrent Investment Advisors LLC raised its position in shares of Veeva Systems by 4.1% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 1,813 shares of the technology company’s stock worth $322,000 after acquiring an additional 71 shares in the last quarter. NEOS Investment Management LLC purchased a new position in shares of Veeva Systems in the 2nd quarter valued at approximately $4,514,000. Continuum Advisory LLC purchased a new position in shares of Veeva Systems in the 2nd quarter valued at approximately $270,000. Finally, Nellore Capital Management LLC boosted its position in shares of Veeva Systems by 8.3% during the second quarter. Nellore Capital Management LLC now owns 484,515 shares of the technology company’s stock valued at $85,987,000 after purchasing an additional 37,214 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Stock Performance

Shares of Veeva Systems stock opened at $274.02 on Friday. The company has a 50-day simple moving average of $220.49 and a two-hundred day simple moving average of $187.95. The stock has a market capitalization of $44.51 billion, a PE ratio of 45.07, a price-to-earnings-growth ratio of 1.17 and a beta of 0.97. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. The firm had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The business’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, equities research analysts forecast that Veeva Systems Inc. will post 6.7 EPS for the current fiscal year.

Insider Buying and Selling

In other Veeva Systems news, insider Thomas Schwenger sold 10,000 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the sale, the insider directly owned 19,449 shares in the company, valued at approximately $5,471,587.17. This trade represents a 33.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on VEEV shares. BMO Capital Markets increased their price objective on Veeva Systems from $175.00 to $270.00 and gave the stock a “market perform” rating in a report on Thursday, August 27th. The Goldman Sachs Group decreased their price target on shares of Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a research note on Thursday, June 4th. Piper Sandler boosted their price objective on shares of Veeva Systems from $295.00 to $320.00 and gave the stock an “overweight” rating in a research note on Thursday, August 27th. BTIG Research restated a “buy” rating and issued a $340.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th. Finally, Mizuho raised their target price on shares of Veeva Systems from $270.00 to $280.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Nineteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and an average target price of $284.46.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher outlook and strong operating momentum: Veeva raised its fiscal 2027 outlook as Vault CRM migrations, research-and-development investment and Falcon AI adoption support revenue growth and expanding profitability. This follows a strong latest quarter, in which revenue increased 17.6% year over year to approximately $928 million and adjusted earnings exceeded analyst expectations. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: AI adoption is broadening: Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally. Veeva also introduced Falcon Safety, an agentic AI product designed for biopharmaceutical safety operations. These developments could deepen customer relationships and expand Veeva’s role in commercial and safety workflows. Why Is Veeva Systems Winning Big in AI For Biopharma?
• Positive Sentiment: Long-term investor support: Commentary highlights Veeva’s recurring-revenue model, Vault CRM migration opportunity and AI expansion as reasons the stock remains attractive for long-term growth investors. Investor Michael Burry has also reportedly remained bullish on Veeva while criticizing Snowflake’s valuation. Burry Remains Bullish on Veeva
• Neutral Sentiment: Valuation and competition remain important considerations: Analysts and portfolio commentary generally support holding VEEV, but warn that market saturation could limit future growth. With the stock trading at a premium earnings multiple after a substantial rally, investors may require continued execution and strong guidance upgrades. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Insider selling may weigh modestly on sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake before the transaction. The sale does not establish a change in business fundamentals, but it can raise caution after the stock’s strong advance. Veeva’s Exiting President Sold $2.8 Million in Stock

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.